Tomohiko Taniguchi, Takeshi Morimoto, Yasuaki Takeji, Shinichi Shirai, Kenji Ando, Hiroyuki Tabata, Ko Yamamoto, Ryosuke Murai, Kohei Osakada, Kotaro Takahashi, Tomohisa Tada, Koichiro Murata, Yuki Obayashi, Yusuke Yoshikawa, Ryusuke Nishikawa, Masashi Amano, Takeshi Kitai, Chisato Izumi, Shojiro Tatsushima, Norio Kanamori, Makoto Miyake, Hiroyuki Nakayama, Masayasu Izuhara, Kazuya Nagao, Kenji Nakatsuma, Yutaka Furukawa, Moriaki Inoko, Masahiro Kimura, Mitsuru Ishii, Shunsuke Usami, Fumiko Nakazeki, Manabu Shirotani, Yasutaka Inuzuka, Koh Ono, Kenji Minatoya, Takeshi Kimura, CURRENT AS Registry‐2 Investigators
These findings suggest that LVEF may provide additional prognostic stratification within severe AS phenotypes, particularly in normal-flow LG AS.
BACKGROUND: Current guidelines classify normal-flow low-gradient (LG) aortic stenosis (AS) with left ventricular ejection fraction (LVEF) ≥50% as "moderate." However, the prognostic impact of LVEF remains incompletely understood across various hemodynamic subtypes of AS.
METHODS: We analyzed 3363 consecutive patients with severe AS from the CURRENT AS Registry-2 (Contemporary Outcomes After Surgery and Medical Treatment in Patients With Severe Aortic Stenosis). Patients were classified into LG AS with normal flow (N=1005), and LG AS with low flow (N=372), and high-gradient AS (N=1986). Patients were further divided according to baseline LVEF: <50%, 50% to 59%, and ≥60%. The primary outcome measure was a composite of death or heart failure hospitalization. Within each hemodynamic subtype, clinical outcomes were compared across baseline LVEF categories of <50%, 50% to 59%, and ≥60% (reference), and unadjusted and adjusted hazard ratios (aHRs) were estimated using Cox proportional hazards models. The median follow-up period in the entire cohort was 763 days.
RESULTS: LVEF <50% was associated with a greater hazard of death or heart failure hospitalization than LVEF ≥60% in all 3 subtypes of AS. LVEF 50% to 59% was associated with a greater hazard of death or heart failure hospitalization than LVEF ≥60% in LG AS with normal flow (aHR, 1.80 [95% CI, 1.35-2.40], P<0.001) and high-gradient AS (aHR, 1.42 [95% CI, 1.13-1.79], P=0.003) with hazards comparable to those with LVEF <50% but not in LG AS with low flow (aHR, 1.13 [95% CI, 0.72-1.79], P=0.59).
CONCLUSIONS: These findings suggest that LVEF may provide additional prognostic stratification within severe AS phenotypes, particularly in normal-flow LG AS.
REGISTRATION: URL: https://center6.umin.ac.jp; Unique Identifier: UMIN000034169.